A study of matrix effects on an LC/MS/MS assay for olanzapine and desmethyl olanzapine

Journal of Pharmaceutical and Biomedical Analysis

Volumn 35, Issue 5, 2004, Pages 1149-1167

  Chin, C ^a   Zhang, Z P ^a   Karnes, H T ^b  

^a Pharmaceutical Product Development   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Anticoagulant; Ion suppression; LC MS MS; Lipemia; Matrix effects; Olanzapine

Indexed keywords

ACETONITRILE; AMMONIUM ACETATE; ANTICOAGULANT AGENT; CITRATE SODIUM; EDETIC ACID; FORMIC ACID; ION; OLANZAPINE;

ANALYSIS OF VARIANCE; ANTICOAGULATION; ARTICLE; DRUG STRUCTURE; ELUTION; HYPERLIPIDEMIA; INFUSION SYSTEM; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TURBIDITY;

ANTICOAGULANTS; BENZODIAZEPINES; CALIBRATION; CHROMATOGRAPHY, LIQUID; CITRATES; EDETIC ACID; HEPARIN; HUMANS; HYPERLIPIDEMIAS; MASS SPECTROMETRY; PIRENZEPINE; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 4344625870     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2004.01.005     Document Type: Article

References (30)

1. Richelson J. Clin. Psychiatry. 57(Suppl. 11):1996;4-11
2. Meltzer H.Y., Fibiger H.C. Neuropsychopharmacology. 14(2):1996;83-85
3. Callaghan J., Bergstrom R.F., Ptak L.R., Beasley C.M. Clin. Pharmacokinet. 37(3):1999;177-193
4. Weigmann H., Hartter S., Maehrlein S., Kiefer W., Kramer G., Dannhardt G., Hiemke C. J. Chromatogr. B. 759:2001;63-71
5. Aravagiri M., Ames D., Wirshing W.C., Marder S.R. Ther. Drug Monit. 19:1997;307-313
6. Bogusz M.J., Kruger K.D., Maier R.D., Erkwoh R., Tuchtenhagen F. J. Chromatrogr. B. 732:1999;257-269
7. Olesen O.V., Poulsen B., Linnet K. Ther. Drug Monit. 23(1):2001;51-55
8. Olesen O.V., Linnet K. J. Chromatogr. B. 714:1998;309-315
9. Boulton D.W., Markowitz J.S., DeVane C.L. J. Chromatogr. B. 759:2001;319-323
10. Raggi M.A., Casamenti G., Mandrioli R., Volterra V. J. Chromatogr. B. 750:2001;137-146
11. Berna M., Shugert R., Mullen J. J. Mass Spectrom. 33:1998;1003-1008
12. E. Ashwood, C. Burtis, Tietz Textbook of Clinical Chemistry, third ed., W.B. Saunders Company, Philadelphia, 1999.
13. Guidance for Industry, Bioanalytical Method Validation, U.S. Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Center for Veterinary Medicine, May 2001.
14. Niessen W.M.A., Tinke A.P. J. Chromatogr. A. 703:1995;37-57
15. Oliveira E.J., Watson D.G. Biomed. Chromatogr. 14:2000;351-372
16. King R., Bonifiglio R., Fernandez-Metzler C., Miller-Stein C., Olah T. J. Am. Soc. Mass Spectrom. 11:2000;942-980
17. Thompson B.A., Iribarne J.V. J. Chem. Phys. 71:1979;4451-4463
18. Choi B.K., Gusev A.I., Hercules D.M. Anal. Chem. 71:1999;4107-4110
19. Burrman D.L., Price P.I., Rudewicz P.J. J. Am. Soc. Mass Spectrom. 7:1996;1099-1105
20. Qu J., Wang Y., Luo G. J. Chromtogr. A. 919:2001;437-441
21. Choi B.K., Hercules D.M., Gusev A.I. J. Chromatogr. A. 907:2001;337-342
22. Pascoe R., Floey J.P., Gusev A.I. Anal. Chem. 73:2001;6014-6023
23. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Anal. Chem. 70:1998;882-889
24. Fu I., Woolf E.J., Matuszewski B.K. J. Pharm. Biomed. Anal. 18:1998;347-357
25. D.E. Vance, J.E. Vance, Biochemisty of Lipids, Lipoproteins and Membranes, Elsevier, New York, 1996.
26. G.J. Nelson, Blood Lipids and Lipoproteins: Quantitation, Composition, and Metabolism, John Wiley & Sons, Inc., New York, 1972.
27. J.N. Delgado, W.A. Remers, Wilson and Gisvold's Textbook of Organic Medicinal and Pharmaceutical Chemistry, 10th ed., Lippincott-Raven Publishers, Philadelphia, 1998.
28. R.L. Anderson, Practical Statistics for Analytical Chemists, Van Nostrand Reinhold Company, New York, 1987.
29. J. Neter, M.H. Kutner, C.J. Nachtsheim, W. Wasserman, Applied Linear Statistical Models, fourth ed., Irwin, Chicago, 1996.
30. W.W. Daniel, Biostatistics: A Foundation for Analysis in the Health Sciences, seventh ed., John Wiley & Sons, Inc., New York, 1999.